Eric A. Forssen
- Biomaterials top 2%
- Molecular Biology
- Oncology top 10%
- Biomedical Engineering
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Zoltán A. TökésMichael C. WillisMichael E. RossRichard T. ProffittAnil TulpuleS CabrialesFranco M. MuggiaParkash S. Gill
- Topics
- Nanoparticle-Based Drug Delivery (6 papers)Chemotherapy-induced cardiotoxicity and mitigation (3 papers)Cancer Treatment and Pharmacology (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyAdvanced Drug Delivery Reviews
- Partner nations
- United States
In The Last Decade
Eric A. Forssen
10 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 84
- Biomaterials 579
- Molecular Biology 500
- Oncology 332
- Biomedical Engineering 198
- Cardiology and Cardiovascular Medicine 178
Countries citing papers authored by Eric A. Forssen
This map shows the geographic impact of Eric A. Forssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Forssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Forssen more than expected).
Fields of papers citing papers by Eric A. Forssen
This network shows the impact of papers produced by Eric A. Forssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Forssen. The network helps show where Eric A. Forssen may publish in the future.
Co-authorship network of co-authors of Eric A. Forssen
This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Forssen. A scholar is included among the top collaborators of Eric A. Forssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Forssen. Eric A. Forssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 213 | |
| 2 | 90 | |
| 3 | Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue. | 85 |
| 4 | 182 | |
| 5 | 9 | |
| 6 | 83 | |
| 7 | Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. | 153 |
| 8 | Improved therapeutic benefits of doxorubicin by entrapment in anionic liposomes. | 89 |
| 9 | 137 | |
| 10 | 63 |
About Eric A. Forssen
Eric A. Forssen is a scholar working on Biomaterials, Virology and Biophysics, having authored 10 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Biomaterials (579 citations), Pharmaceutical Science (83 citations) and Oncology (332 citations). Eric A. Forssen has collaborated with scholars based in United States. Frequent co-authors include Zoltán A. Tökés, Michael C. Willis, Michael E. Ross, Richard T. Proffitt, Anil Tulpule, S Cabriales, Franco M. Muggia, Parkash S. Gill, Howard A. Liebman and Byron M. Espina. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.